| P/E (FY) | 1.0 | Sales (TTM) | NOK 107.2M |
| Earnings (TTM) | -NOK 337.4M | ROE | — |
| Net Margin | −314.78% | ROIC | −323.84% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 278.55% |
Aqua Bio Technology ASA manufactures and sells ingredients for the cosmetics industry in Norway. Its products include Aquabeautine XL, a proprietary skincare ingredient, and Spirulysat, an antioxidant- and vitamin-enriched spirulina for cosmetic use, distributed through the internet, retail stores, and skincare clinics. The company was founded in 2000 and is based in Oslo.
| Market Cap | — | Trading Days | 4016 |
| 52W High | 71.40 |
| 52W Low | 4.00 |
| % Off High | −93.17% |
| YTD | −78.71% | 1Y | −89.14% |
| 3Y | −97.68% | 5Y | −99.51% |
| 10Y | −99.22% | Since incept. (ann.) | −25.14% |
| Ann. Volatility (1Y) | 109.31% | Ann. Volatility (3Y) | 159.27% |
| Sharpe (1Y) | −1.54 | Sharpe (3Y) | −0.17 |
| Max Drawdown (1Y) | −92.71% | Max Drawdown (3Y) | −98.82% |
| Beta (3Y, vs SPY) | 0.46 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| LLY | ELI LILLY & Co | $1.14T | 52.7 |
| JNJ | JOHNSON & JOHNSON | $639.90B | 24.1 |
| ONC | BeOne Medicines Ltd. | $472.90B | 1722.2 |
| ABBV | AbbVie Inc. | $465.20B | 111.6 |
| MRK | Merck & Co., Inc. | $321.97B | 17.9 |
| AMGN | AMGEN INC | $209.21B | 27.2 |
| ABT | ABBOTT LABORATORIES | $188.12B | 29.0 |
| GILD | GILEAD SCIENCES, INC. | $164.79B | 19.6 |
| PFE | PFIZER INC | $143.34B | 18.5 |
| SYK | STRYKER CORP | $135.04B | 41.9 |
| BMY | BRISTOL MYERS SQUIBB CO | $128.90B | 18.2 |
| ISRG | INTUITIVE SURGICAL INC | $124.74B | 44.9 |
